title: Home therapy with continuous infusion of factor VIII after minor surgery or serious haemorrhage.
abstract: Administration of factor VIII (F VIII) concentrates by continuous infusion is now routinely used at several haemophilia centers but almost exclusively for hospitalized patients. We evaluated various aspects of home therapy with continuous infusion of an immunoaffinity purified F VIII concentrate (Monoclate P®, Armour) in patients who would normally have been treated with high doses in bolus injections or with continuous infusion as in-patients. Twenty haemophilia A patients, eight after minor surgery and 12 for serious haemorrhage, received continuous infusion with undiluted F VIII by a minipump for a mean of 0.9 days in the hospital, followed by 3.3 days at home. Infusion bags were exchanged every 2.5 days. No haemorrhagic complications occurred, and five haemorrhages that had been resistant to treatment with bolus injections responded promptly to the continuous infusion. There were no technical problems and patient compliance and acceptance was good. We find this mode of therapy safe, efficacious and convenient for the patients as well as for the staff.
authors.affiliation: The National Haemophilia Centre, The Chaim Sheba Medical Centre, Tel Hashomer 52621, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Varon
authors.affiliation: The National Haemophilia Centre, The Chaim Sheba Medical Centre, Tel Hashomer 52621, Israel.
authors.forename: S
authors.initials: S
authors.lastname: Schulman
authors.affiliation: The National Haemophilia Centre, The Chaim Sheba Medical Centre, Tel Hashomer 52621, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Bashari
authors.affiliation: The National Haemophilia Centre, The Chaim Sheba Medical Centre, Tel Hashomer 52621, Israel.
authors.forename: U
authors.initials: U
authors.lastname: Martinowitz
keywords: continuous infusion; haemophilia A; haemorrhage; surgery